Avanir Sues Par, Actavis To Block Generic Nuedexta
Avanir Pharmaceuticals Inc. sued Actavis Inc. and Par Pharmaceutical Inc. in Delaware on Wednesday alleging their planned generic versions of involuntary-emotion drug Nuedexta would violate two patents....To view the full article, register now.
Already a subscriber? Click here to view full article